fbpx
August 5, 2022

How Retraining Your Brain Could Help With Lower Back Pain How Retraining Your Brain Could Help With Lower Back Pain

Are you among the hundreds of millions of people worldwide with low back pain? If so, you may be familiar with standard treatments like surgery, shots, […]
August 5, 2022

Increasing Data Link ME/CFS, Long COVID, and Dysautonomia Increasing Data Link ME/CFS, Long COVID, and Dysautonomia

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Emerging evidence is shedding light on the common underlying mechanisms contributing to […]
August 5, 2022

Treatments Explored to Ease ME/CFS and Long COVID Symptoms Treatments Explored to Ease ME/CFS and Long COVID Symptoms

A variety of treatments, most already commercially available, are under investigation for treating the constellation of overlapping symptoms associated with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), “long […]
August 5, 2022

Doc Faces Retaliation After Alleging Data Manipulation in Study Doc Faces Retaliation After Alleging Data Manipulation in Study

A rheumatologist was suspended from a professional society and his license to practice medicine was threatened after he raised concerns about data manipulation in a published […]
August 2, 2022

Ustekinumab Becomes Second Biologic Approved for PsA in Kids Ustekinumab Becomes Second Biologic Approved for PsA in Kids

The US Food and Drug Administration has approved the dual interleukin (IL)-12 and IL-23 inhibitor ustekinumab (Stelara) for the treatment of juvenile psoriatic arthritis (jPsA) in […]
July 29, 2022

Upadacitinib Gets European Nod for Nonradiographic AxSpA Upadacitinib Gets European Nod for Nonradiographic AxSpA

Upadacitinib (Rinvoq) has been approved by the European Commission for the treatment of active nonradiographic axial spondyloarthritis (nr-axSpA) in adults whose response to NSAIDS is inadequate, […]
July 28, 2022

FDA Approves Belimumab for Children With Lupus Nephritis FDA Approves Belimumab for Children With Lupus Nephritis

The US Food and Drug Administration (FDA) has approved belimumab (Benlysta) for treating active lupus nephritis (LN) in children aged 5–17 years. The drug can now […]
July 28, 2022

TNF Inhibitor Use for RA Shows Beneficial Effect in Pregnancy TNF Inhibitor Use for RA Shows Beneficial Effect in Pregnancy

Women with well-controlled rheumatoid arthritis (RA) who used a tumor necrosis factor (TNF) inhibitor during pregnancy gave birth to infants with higher birth weight than did […]
July 27, 2022

Vitamin D Supplements Do Not Lower Risk of Fractures Vitamin D Supplements Do Not Lower Risk of Fractures

Taking vitamin D supplements did not significantly reduce the risk of fractures among adults in midlife and older adults, compared with placebo, according to results from […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0